Characteristics | All V-A ECMO (n = 150) | Patient without BSI (n = 100) | Patient with BSI (n = 50) | p |
---|---|---|---|---|
Age (years) | 58 (16) | 59 (16) | 55 (15) | 0.14 |
Male gender | 104 (69) | 68 (68) | 36 (72) | 0.62 |
BMI (kg/m)2 | 25.4 (22.8–29.0) | 24.7 (22.8–28.7) | 27.1 (22.6–29.4) | 0.13 |
Comorbidities | ||||
COPD | 10 (7) | 7 (7) | 3 (6) | 0.82 |
Cirrhosis | 3 (2) | 1 (1) | 2 (4) | 0.22 |
Long-term corticosteroid | 7 (5) | 4 (4) | 3 (6) | 0.58 |
Diabetes | 36 (24) | 27 (27) | 9 (18) | 0.22 |
V-A ECMO for post-cardiotomy shock | 65 (43) | 43 (43) | 22 (44) | 0.91 |
Including primary graft failure after heart transplantation | 14 (21) | 5 (11) | 9 (41) | 0.01 |
V-A ECMO for acute heart failure | 85 (57) | 57 (57) | 28 (56) | 0.91 |
Including refractory cardiac arrest | 39 (26) | 12 (24) | 27 (27) | 0.69 |
Percutaneous V-A ECMO insertion | 9 (6) | 8 (8) | 1 (2) | 0.27 |
Intra-aortic balloon pump | 26 (17) | 20 (20) | 6 (12) | 0.22 |
Lactate level at day 0 (mmol/L) | 5.2 (3.0–9.1) | 6.1 (3.7–10.3) | 3.8 (2.2–8.3) | 0.003 |
Creatinine level at day 0 (µmol/L) | 159 (98) | 154 (93) | 169 (109) | 0.39 |
SAPS II | 54 (38–70) | 56 (40–74) | 50 (37–66) | 0.19 |
Admission SOFA score | 13 (11–15) | 14 (12–16) | 12 (11–15) | 0.10 |
Vasoactive–inotropic score | 70 (34–139) | 68 (36–130) | 73 (29–141) | 0.91 |